T-DM1 (ado-trastuzumab emtansine)

ado-trastuzumab emtansine · Genentech (Roche)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for T-DM1 (ado-trastuzumab emtansine), covering 2023-10-11 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer [Phase 2]